Dr. Henrieta Fraser

Dr. Henrieta Fraser has extensive work experience in the field of GMP operations and cell therapy development. Dr. Henrieta currently holds the position of Vice President Technical Operations at Achilles Therapeutics plc since September 2022. Prior to this, they served as the Senior Director of GMP Operations and Director of GMP Operations at the same company. Dr. Fraser also has experience as the Head of GMP Manufacturing at Achilles Therapeutics and as a GMP Production Manager.

Before joining Achilles Therapeutics, Dr. Fraser worked as a Senior Process Development Scientist at Cell Therapy Catapult from March 2014 to May 2017. Dr. Henrieta also served as a GMP Production Scientist at the MRC Centre for Transplantation, King's College London from July 2012 to March 2014.

Dr. Fraser began their career as a Postdoctoral Research Associate at King's College London, where they focused on translational and clinical research in the field of cell therapy. Dr. Henrieta has also worked as a Postdoctoral Research Associate at the Department of Immunology, Imperial College London.

Dr. Fraser completed their PhD at Comenius University, specializing in immunogenetics. Their research focused on the association of HLA antigens and diseases, particularly Vitiligo and dermal diseases associated with H. pylori infection.

Overall, Dr. Fraser's work experience demonstrates their expertise in GMP operations, cell therapy development, and translational research.

Dr. Henrieta Fraser completed their education at Univerzita Komenského v Bratislave from 1989 to 1994, obtaining an MSc and PhD in Molecular Biology and Genetics, with a specialization in Immunogenetics.